Continuing Medical Education - CME Courses

Popular

• • 

    

    Jeffery D. Dunn, PharmD, MBA

    Peer

  • 

    

    Gary M. Owens, MD

    Peer

  • 

    

    Anita L. Nelson, MD

    Peer

  9

  

  RestartResume

  Focus on the New Menopause Management Horizon: Improving Outcomes Through Managed Care

  Focus on the New Menopause Management Horizon: Improving Outcomes Through Managed Care

  0.25 credits

• • 

    

    Christie M. Ballantyne, MD

    Peer

  • 

    

    Gregory Pokrywka MD, FACP, FNLA, FASPC, NCMP

    Peer

  • 

    

    Joseph Saseen, PharmD, BCPS, BCACP, CLS

    Peer

  • 

    

    Karol Watson, MD, PhD

    Peer

  14

  

  RestartResume

  Adopting the New Therapeutic “Lineup” to Manage ASCVD - Central

  Adopting the New Therapeutic “Lineup” to Manage ASCVD - Central

  3.50 credits

• • 

    

    Sergio Schwartzman, MD

    Peer

  • 

    

    April W. Armstrong, MD, MPH

    Peer

  • 

    

    Philip J. Mease, MD, MACR

    Peer

  4

  

  RestartResume

  Raising the Bar in PsA: Integrating Structural Assessment to Improve Long-Term Outcomes

  Raising the Bar in PsA: Integrating Structural Assessment to Improve Long-Term Outcomes

  0.50 credits

• • 

    

    Mitchell D. Creinin, MD

    Peer

  3

  

  RestartResume

  Contraceptive Continuity of Care During the COVID-19 Pandemic—A “Voice of Patient” Curriculum

  Contraceptive Continuity of Care During the COVID-19 Pandemic—A “Voice of Patient” Curriculum

  0.25 credits

• • 

    

    Javed Butler, MD, MBA, MPH

    Peer

  • 

    

    Stefan D. Anker, MD, PhD

    Peer

  17

  

  RestartResume

  Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results

  Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results

  0.25 credits

• • 

    

    George I. Papakostas, MD

    Peer

  • 

    

    Larry Culpepper, MD, MPH

    Peer

  6

  

  RestartResume

  Modifying Treatment Strategies to Address Poor Response in Major Depressive Disorder

  Modifying Treatment Strategies to Address Poor Response in Major Depressive Disorder

  0.50 credits

• • 

    

    Heather Wakelee, MD, FASCO

    Peer

  2

  

  RestartResume

  Adjuvant Treatment of Early Non–Small Cell Lung Cancer in the Era of Immunotherapy

  Adjuvant Treatment of Early Non–Small Cell Lung Cancer in the Era of Immunotherapy

  0.50 credits

• • 

    

    Adrienne W. Scott, MD

    Peer

  • 

    

    Rajendra Apte, MD, PhD

    Peer

  • 

    

    Jennifer I. Lim, MD, FARVO

    Peer

  5

  

  RestartResume

  Sharpening the Focus: Identifying Treatment Strategies for Diabetic Retinopathy

  Sharpening the Focus: Identifying Treatment Strategies for Diabetic Retinopathy

  0.25 credits

• • 

    

    Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  5

  

  RestartResume

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  1.00 credits

• • 

    

    Josep Comin-Colet, MD, PhD

    Peer

  10

  

  RestartResume

  Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure

  Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure

  0.25 credits

• • 

    

    Rahul N. Khurana, MD

    Peer

  • 

    

    Jennifer K. Sun, MD, MPH

    Peer

  5

  

  RestartResume

  What You Need to Know About Strategies for Treating NPDR

  What You Need to Know About Strategies for Treating NPDR

  0.25 credits

• • 

    

    J. Fernando Arevalo, MD, PhD

    Peer

  • 

    

    W. Lloyd Clark, MD

    Peer

  3

  

  RestartResume

  The Future Is Now: Latest Surgical Techniques for Anti-VEGF Delivery

  The Future Is Now: Latest Surgical Techniques for Anti-VEGF Delivery

  0.25 credits

• • 

    

    Lyudmila Bazhenova, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  6

  

  RestartResume

  The Emerging Role of HER2 (ERBB2) Mutations in NSCLC

  The Emerging Role of HER2 (ERBB2) Mutations in NSCLC

  0.25 credits

• • 

    

    Neal Bhatia, MD

    Peer

  • 

    

    Jeffrey Sugarman, MD, PhD

    Peer

  3

  

  RestartResume

  Case Review: Rethinking Benzoyl Peroxide in Rosacea

  Case Review: Rethinking Benzoyl Peroxide in Rosacea

  0.25 credits

• • 

    

    Ileana L. Piña, MD, MPH, FAHA, FACC

    Peer

  • 

    

    Adrian F. Hernandez, MD, MHS

    Peer

  1

  

  RestartResume

  How Do I Optimize GDMT with New Therapies in My Patients Following a Worsening HF Event?

  How Do I Optimize GDMT with New Therapies in My Patients Following a Worsening HF Event?

  0.25 credits